SOURCE: MIT Holding, Inc.
LOS ANGELES, CA--(Marketwired - Aug 22, 2014) - MIT Holding, Inc. (OTCQB: MITD) announces the hiring of New York City-based ProActive Capital Group, LLC (PCG), a leading capital markets advisory and communication strategies firm, to assist with achieving investor and corporate awareness.
PCG assists emerging and developing companies to achieve financial objectives through active, multi-channel engagement with investors to facilitate dialogue with the investment community and public at large.
"We are familiar with the quality of work and investor access that ProActive Capital provides and believe they are wonderfully suited to deliver our message to the community of investors seeking to profit from the healthcare sector. Their multi-channel approach makes them a good match for our investor awareness needs and we look forward to updating our shareholders as we move ahead," stated Walter Drakeford, Chairman and President MIT Holding.
Jeff Ramson, CEO of ProActive Capital Group, states, "The unique value to patients of MIT Holding's professional outpatient medical care and custom prescription solutions was clear to us from the beginning of our discussions, and we are pleased to be able to bring this opportunity to our community of investors, media, and trade professionals, commented "We look forward to working with their team and broadening MIT Holding's exposure through our network."
For further information click the following:
Click here for recent news on MITD.
Click here for current SEC filings for MITD.
About MIT Holding, Inc.:
Through its wholly owned subsidiaries, MIT distributes wholesale pharmaceuticals in the United States, administers intravenous infusions and, in Georgia, operates ambulatory centers where therapies are administered and sells and rents home medical equipment. MIT has initiated government contacts to obtain the necessary approvals to import pharmaceutical products into the Americas. MIT's domestic wholesale pharmaceutical distribution is conducted through Medical Infusion Technologies, Inc., which sells pharmaceuticals to end-users and other wholesalers in the U.S.
This news release contains "forward-looking statements" as defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements regarding beliefs, plans, expectations or intentions contain reasonable expectations, there can be no assurance that such beliefs, plans, expectations, intentions will prove to be accurate.